Related Experiment Videos
Towards intelligent anticancer drug screening in the post-genome era?
1ZENECA Pharmaceuticals, Cancer Metabolism and Endocrine Research Department, Macclesfield, UK.
Anti-Cancer Drug Design
|November 20, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance.
Clinical pharmacology and therapeutics·2013
Topoisomerase I/II selectivity among derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide (DACA).
Anti-cancer drug design·2002
The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?
Anti-cancer drug design·2002
Photokilling of cultured tumour cells by the porphyrin derivative CF3.
Anti-cancer drug design·2002
Cyclohexylamino-demethoxy-hypocrellin B and photodynamic therapy decreases human cancer in vitro.
Anti-cancer drug design·2002
Synthesis and anticancer activity of nordihydroguaiaretic acid (NDGA) and analogues.
Anti-cancer drug design·2002
Patient-Derived Organoid and Single-Cell Multiomics Reveal Evolution Driven by CEACAM6/KRT19-Mediated Heterogeneity.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Primary Cardiac Paraganglioma Management and Resection With Rare Recurrent Metastasis.
JACC. Case reports·2026
Emerging therapeutic strategies for triple-negative breast cancer using ruthenium, iridium, and rhenium complexes.
Dalton transactions (Cambridge, England : 2003)·2026
Metal-Phenolic Networks: Emerging Nanoarchitectures for Cancer Therapy.
Angewandte Chemie (International ed. in English)·2026
Intracellular Delivery of Antibody-Based Therapeutics for Targeted Oncogenic c-Myc Degradation in Mammalian Cells and Mice.
Angewandte Chemie (International ed. in English)·2026